羊栖菜多糖复方制剂抗辐射作用的实验研究

目的 研究羊柄菜多糖复方制剂对γ射线照射小鼠的抗辐射作用.方法 将小鼠分为空白对照组、模型对照组及羊栖菜多糖复方制剂低[0.692g/(kg·d)]、中[2.075g/(kg·d)]、高[4.150g/(kg·d)]3个剂量组,以方格星虫提取物为阳性对照组,每天灌胃给药1次,灌胃2周后用60Co γ射线进行1次全身照射.测定小鼠外周血白细胞(WBC)、血小板和血细胞计数,以及脾指数(TI)、胸腺指数(SI)、骨髓有核细胞计数(BMWC)、血清超氧化物歧化酶(SOD)活性和丙二醛(MDA)含量等指标.结果 3个剂量组小鼠与模型组比较,WBC均有上升趋势,但仅中剂量组在照后第14天与模型组差异有统计学意义(P＜0.05).3个剂量组TI均明显高于模型组(P＜0.05),SI和BMNC仅中、高剂量组明显高于模型组(P＜0.05),SOD低、中剂量组明显高于模型组(P＜0.05),MDA中、高剂量组低于模型组(P＜0.05或P＜0.01).结论 羊栖菜多糖复方制剂能有效提高小鼠的抗辐射能力.     

术中输注氨基酸对硬膜外阻滞复合全麻开胸手术患者围术期体温的影响

目的评价术中输注氨基酸对硬膜外阻滞复合全麻食管癌和贲门癌手术患者围术期深部体温和代谢的影响。方法择期食管癌和贲门癌手术患者21例,ASAⅠ或Ⅱ级,随机分为3组(n =7):从麻醉诱导开始至手术结束,分别静脉输注氨基酸混合液240kJ·h-1(AA组)、等容量乳酸钠林格氏液(LR组)、葡萄糖溶液240kJ·h-1(GLU组)。麻醉诱导前至术后2h每5分钟测定鼓膜温度,于麻醉诱导前即刻、手术开始后1h和术后1h检测指尖血糖,采用4分表法评价术后2h内寒战的发生情况,采用间接测热仪测定术前与术后氧耗。结果与麻醉诱导前即刻比较,术后30min LR组和GLU组氧耗降低,AA组氧耗升高(P<0.01),术后2h LR组、GLU组鼓膜温度降低(P<0.05),AA组差异无统计学意义(P>0.05);与LR组和GLU组比较,AA组术后2h内寒战发生例数减少(P< 0.05),术后30min氧耗增多(P<0.05),LR组与GLU组比较差异无统计学意义(P>0.05)。结论硬膜外阻滞复合全麻开胸手术患者术中静脉输注氨基酸可通过提高基础代谢率,缓解围术期深部体温降低,减少术后寒战发生,而输注葡萄糖不产生此效应。     

残杀威对舰艇蜚蠊的抗性调查与防制研究

目的：观察残杀威对德国小蠊的药效。方法：采用果酱瓶药膜法和现场试验评价效果。结果残杀威对德国小蠊敏感品系的平均KT50为13．86min，现场品系8个调查点的KT50为11．25—38．02min，对抗氯菊酯品系KT50为16．06-23．37min，72h死亡率均为100％；现场试验，4周后的杀灭率仍达90．58％。结论：残杀威对德国小蠊现场品系为一般击倒；对抗氯菊酯品系尚未形成交互抗性，其水乳剂防制舰艇蜚蠊效果满意。     

Comparison of mortality risk associated with bacteremia due to methicillin-resistant and methicillin-susceptible Staphylococcus aureus.

OBJECTIVE: To quantify the clinical impact of methicillin-resistance in Staphylococcus aureus causing infection complicated by bacteremia in adult patients, while controlling for the severity of patients' underlying illnesses. DESIGN: Retrospective cohort study from October 1, 1995, through December 31, 2003. PATIENTS AND SETTING: A total of 438 patients with S. aureus infection complicated by bacteremia from a single Veterans Affairs healthcare system. RESULTS: We found that 193 (44%) of the 438 patients had methicillin-resistant S. aureus (MRSA) infection and 114 (26%) died of causes attributable to S. aureus infection within 90 days after the infection was identified. Patients with MRSA infection had a higher mortality risk, compared with patients with methicillin-susceptible S. aureus (MSSA) infections (relative risk, 1.7 [95% confidence interval, 1.3-2.4]; P<.01), except for patients with pneumonia (relative risk, 0.7 [95% confidence interval, 0.4-1.3]). Patients with MRSA infections were significantly older (P<.01), had more underlying diseases (P=.02), and were more likely to have severe sepsis in response to their infection (P<.01) compared with patients with MSSA bacteremia. Patients who died within 90 days after S. aureus infection was identified were significantly older (P<.01) and more likely to have severe sepsis (P<.01) and pneumonia (P=.01), compared with patients who survived. After adjusting for age as a confounder, comorbidities, and pneumonia as an effect modifier, S. aureus infection-related mortality remained significantly higher in patients with MRSA infection than in those with MSSA infection, among those without pneumonia (hazard ratio, 1.8 [95% confidence interval, 1.2-3.0]); P<.01. CONCLUSIONS: The results of this study suggest that patients with MRSA infections other than pneumonia have a higher mortality risk than patients with MSSA infections other than pneumonia, independent of the severity of patients' underlying illnesses.     

实时荧光定量PCR检测PML-RARα融合基因的临床应用研究

目的 利用PML-RARα融合基因作为标志物,应用实时荧光定量PCR技术,监测急性早幼粒细胞白血病(APL)微小残留病(minimal residual disease,MRD)患者体内病毒的状态,探讨预测APL复发风险的方法.方法 利用本实验室建立的定量检测APL患者PML-RARα融合基因的方法,对25例处于初诊、完全缓解(complete remission,CR)、复发等不同阶段的APL患者进行了PML-RARα融合基因的定量检测,并对其中6例患者的MRD状态进行了动态监测.结果 应用荧光定量PCR技术分析患者初诊、CR和复发状态的PML-RARα基因对数值(lg)水平,结果 显示有统计学意义(x2=6.847,P＜0.05);随访期患者的PML-RARα对数值(lg)水平变化较大:初诊时较高(-0.61±0.79),CR时下降(-1.31±0.62),复发时又出现上升(-0.57±0.44),提示若该患者在CR时的对数值呈现上升趋势,患者复发的机率大.结论 应用实时荧光定量(RQ)-PCR技术定量检测PML-RARα融合基因,对监测APL患者MRD状态具有临床适用性,随访期的MRD动态追踪监测具有预后价值.     

电子文献数据库收录期刊的质量瑕疵及对策

 

以限题检索为手段，以收录期刊所载论文为指标，比较分析了国内常用的4种医学电子文献数据库收录医学期刊的质量。结果表明4种医学电子文献数据库均存在收录“非法医学期刊”之瑕疵，但各数据库的收录量有差异。提示广大读者和电子文献数据库使用者注意，并针对此问题提出了相应的对策和建议。

     

急性输液反应的影响因素及防治措施

目的 对临床发生的急性输液反应进行分析，找出发生的原因，探讨预防措施。方法对201885例次输液治疗中的52例次输液反应资料进行分析。结果 经分析，属药物因素27例（52％），属操作因素11例（21％），属病人因素11例（21％），属输液器具因素3例（6％）。结论 把好药品和操作关，改善操作环境，严格操作规程是减少输液反应的关键。     

Clinical Experience in TCM Differential Treatment of Fatty Liver

In recent years, with improvement of living standard, changes in dietary structure and technical progress in medical tests, the rate of detecting fatty liver has been rising, hence constant increase in its incidence. Based on the TCM principle for differentiating syndromes, the authors have achieved remarkable curative effects in treating fatty liver. TCM Conception on Fatty Liver There is no fatty liver in the terms of TCM. However, according to its clinical manifestations, the disease may belong to the categories of “abdominal mass”, “mass at hypochondria”, “hypochondriac pain”, “accumulation of phlegm with stasis”. Its etiology and pathogenesis mainly lie in uncontrolled diet or     

拉米夫定阻断乙型肝炎病毒宫内传播的临床探讨

【目的】研究拉米夫定对HBsAg阳性孕妇的乙肝病毒 (HBV)宫内阻断作用。【方法】拉米夫定组 43例 ,孕 2 8周起口服拉米夫定 ,每天 10 0mg至产后 30d。对照组 5 2例 ,未予用药。两组孕妇均于孕 2 8周、分娩前 ,其新生儿于生后 2 4h内免疫接种前抽静脉血检测HBsAg、HBeAg及HBV的定量。【结果】拉米夫定组孕妇HBV的DNA水平显著下降 (P <0 0 5 ) ,其新生儿宫内感染率 (16 3% )明显低于对照组 (32 7% ) ,P <0 0 5。两组孕妇及其新生儿未发现有不良反应。【结论】携带HBV孕妇产前服用拉米夫定可有效减少HBV宫内感染发生率。